|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.202 SEK | -2.88% |
|
+6.09% | -97.98% |
| 16/05 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 | |
| 16/05 | Xbrane Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Xbrane Biopharma AB (publ) at its annual Meeting of Shareholders held on 2 May 2024, announced that Kristoffer Bissessar was elected as new director.
| 1st Jan change | Capi. | |
|---|---|---|
| -97.98% | 2.97Cr | |
| +33.63% | 5.08TCr | |
| -0.09% | 4.28TCr | |
| +49.62% | 4.2TCr | |
| -4.96% | 2.95TCr | |
| +11.18% | 2.61TCr | |
| -21.95% | 1.91TCr | |
| +8.61% | 1.31TCr | |
| +28.31% | 1.22TCr | |
| +24.73% | 1.21TCr |
XBRANE BIOPHARMA AB 
